Pulmatrix, Inc. financial data

Symbol
PULM on Nasdaq
Industry
Pharmaceutical Preparations
Location
945 Concord Street, Suite 1217, Framingham, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Ruthigen, Inc. (to 6/16/2015)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 648 % -5.25%
Debt-to-equity 49.6 % +15.2%
Return On Equity -63.1 % +1.59%
Return On Assets -42.2 % +5.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.65M shares 0%
Common Stock, Shares, Outstanding 3.65M shares 0%
Entity Public Float 9.79M USD -37%
Weighted Average Number of Shares Outstanding, Basic 3.65M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 3.65M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10M USD +47%
Research and Development Expense 10.7M USD -35.2%
General and Administrative Expense 6.75M USD -5.97%
Operating Income (Loss) -10M USD +40.4%
Nonoperating Income (Expense) 380K USD -35.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -9.66M USD +40.6%
Earnings Per Share, Basic -2.65 USD/shares +40.2%
Earnings Per Share, Diluted -2.65 USD/shares +31.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.8M USD -49.5%
Accounts Receivable, after Allowance for Credit Loss, Current 23K USD -97.3%
Assets, Current 11.4M USD -50.7%
Property, Plant and Equipment, Net 1.11M USD +446%
Operating Lease, Right-of-Use Asset 10.1M USD +1374%
Other Assets, Noncurrent 54K USD -75.1%
Assets 11.5M USD -68.7%
Accounts Payable, Current 373K USD -47.2%
Employee-related Liabilities, Current 12K USD -98.3%
Accrued Liabilities, Current 2.75M USD +98.4%
Liabilities, Current 590K USD -86.7%
Operating Lease, Liability, Noncurrent 8.23M USD
Liabilities 590K USD -96.5%
Retained Earnings (Accumulated Deficit) -295M USD -3.38%
Stockholders' Equity Attributable to Parent 10.9M USD -45.1%
Liabilities and Equity 11.5M USD -68.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.72M USD +44.8%
Net Cash Provided by (Used in) Financing Activities 53K USD
Net Cash Provided by (Used in) Investing Activities -154K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 3.65M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.87M USD +41.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 42.3M USD -21.2%
Deferred Tax Assets, Valuation Allowance 24.5M USD +21.9%
Deferred Tax Assets, Gross 27.3M USD +34.6%
Operating Lease, Liability 24K USD -93.3%
Payments to Acquire Property, Plant, and Equipment 154K USD
Lessee, Operating Lease, Liability, to be Paid 24K USD -93.3%
Property, Plant and Equipment, Gross 2.9M USD -2.68%
Operating Lease, Liability, Current 24K USD -93.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.37M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.33M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +35.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.62M USD +46742%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.4M USD
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 505K USD +121%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.44M USD
Operating Lease, Payments 573K USD -85.7%
Additional Paid in Capital 306M USD +0.23%
Depreciation, Depletion and Amortization 59K USD +84.4%
Share-based Payment Arrangement, Expense 695K USD -32.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%